Focus:
Opthalmic
-
13 February 2020 News
3D visualisation tech launched for UK cancer patients
GenesisCare has launched the Brainlab Mixed Reality Viewer at its Oxford centre for diagnostics, oncology and wellbeing, offering cancer patients a novel way to visualise their treatment.
-
10 February 2020 News
Magseed cleared for long-term lymph node marking in Europe
UK-headquartered seed localisation company Endomag has received an extended indication in Europe for long-term use of its Magseed magnetic marker in any soft tissue to identify suspicious lymph nodes before...
-
6 February 2020
FDA gives Breakthrough Device designation to EyeYon’s EndoArt
The US Food and Drug Administration (FDA) has granted Breakthrough Status designation to EyeYon Medical’s artificial endothelial layer implant EndoArt.
-
3 February 2020 News
Assessing ‘stickiness’ of tumour cells could improve cancer prognosis
Researchers at the University of California San Diego have created a microfluidic device which measures how ‘sticky’ cancer cells are and could improve prognostic evaluation of patient tumours.
-
29 January 2020 News
Bone marrow chip opens research options for Shwachman-Diamond syndrome
A new research tool that mimics the behaviour of diseased bone marrow has provided a new strategy for understanding the bone marrow disease Shwachman-Diamond syndrome (SDS).
-
14 January 2020 Analysis
From Grinders to Biohackers: where medical technology meets body modification
A new generation of patients are demanding medical interventions that not only make it easier to manage medical conditions, but also enhance their day-to-day lives. Engineers and researchers have responded...
-
12 December 2019 News
Bausch + Lomb expands intraocular lens portfolio
Canadian eye health products company Bausch + Lomb has expanded its enVista family of intraocular lenses to deliver improved optic recovery after delivery during cataract surgery.
-
20 November 2019 News
Baring Private Equity Asia signs agreement to buy Lumenis
Baring Private Equity Asia’s (BPEA) affiliated private equity funds have signed an agreement to buy Lumenis, a provider of speciality energy-based medical devices.
-
5 November 2019 News
Researchers develop novel biopsy for retinoblastoma
Clinicians at Children’s Hospital Los Angeles have found a way to glean genetic tumour information from the aqueous humour liquid inside the eye, which could provide a novel way to...
-
16 October 2019 Analysis
Pearse Keane Q&A: how open access AI is bringing ophthalmology into focus
Ophthalmic research is one of the areas of medicine which stands to benefit most from the AI revolution. In an interview from New Scientist Live 2019, Moorfields Eye Hospital ophthalmologist...